These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20199107)

  • 1. Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.
    Ahmed AH; Ptak CP; Oswald RE
    Biochemistry; 2010 Apr; 49(13):2843-50. PubMed ID: 20199107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
    Ahmed AH; Oswald RE
    J Med Chem; 2010 Mar; 53(5):2197-203. PubMed ID: 20163115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A desensitization-selective potentiator of AMPA-type glutamate receptors.
    Sekiguchi M; Nishikawa K; Aoki S; Wada K
    Br J Pharmacol; 2002 Aug; 136(7):1033-41. PubMed ID: 12145103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives.
    Ptak CP; Ahmed AH; Oswald RE
    Biochemistry; 2009 Sep; 48(36):8594-602. PubMed ID: 19673491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the S1S2 glutamate binding domain of GLuR3.
    Ahmed AH; Wang Q; Sondermann H; Oswald RE
    Proteins; 2009 May; 75(3):628-37. PubMed ID: 19003990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
    Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
    Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel allosteric potentiator of AMPA receptors: 4--2-(phenylsulfonylamino)ethylthio--2,6-difluoro-phenoxyaceta mide.
    Sekiguchi M; Fleck MW; Mayer ML; Takeo J; Chiba Y; Yamashita S; Wada K
    J Neurosci; 1997 Aug; 17(15):5760-71. PubMed ID: 9221774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
    Shen Y; Lu T; Yang XL
    Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Mobility of the Apo State and TARP Stoichiometry Dictate the Gating Behavior of Alternatively Spliced AMPA Receptors.
    Dawe GB; Kadir MF; Venskutonytė R; Perozzo AM; Yan Y; Alexander RPD; Navarrete C; Santander EA; Arsenault M; Fuentes C; Aurousseau MRP; Frydenvang K; Barrera NP; Kastrup JS; Edwardson JM; Bowie D
    Neuron; 2019 Jun; 102(5):976-992.e5. PubMed ID: 31053408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
    Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
    J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain.
    Krintel C; Harpsøe K; Zachariassen LG; Peters D; Frydenvang K; Pickering DS; Gajhede M; Kastrup JS
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1645-52. PubMed ID: 23999288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
    Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants.
    Quirk JC; Siuda ER; Nisenbaum ES
    J Neurosci; 2004 Dec; 24(50):11416-20. PubMed ID: 15601947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for positive allosteric modulation of AMPA and kainate receptors.
    Frydenvang K; Pickering DS; Kastrup JS
    J Physiol; 2022 Jan; 600(2):181-200. PubMed ID: 33938001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Druggability Simulations and X-Ray Crystallography Reveal a Ligand-Binding Site in the GluA3 AMPA Receptor N-Terminal Domain.
    Lee JY; Krieger J; Herguedas B; García-Nafría J; Dutta A; Shaikh SA; Greger IH; Bahar I
    Structure; 2019 Feb; 27(2):241-252.e3. PubMed ID: 30528594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2.
    Krintel C; Dorosz J; Larsen AH; Thorsen TS; Venskutonytė R; Mirza O; Gajhede M; Boesen T; Kastrup JS
    FEBS J; 2021 Feb; 288(3):995-1007. PubMed ID: 32543078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform-specific early trafficking of AMPA receptor flip and flop variants.
    Coleman SK; Möykkynen T; Cai C; von Ossowski L; Kuismanen E; Korpi ER; Keinänen K
    J Neurosci; 2006 Oct; 26(43):11220-9. PubMed ID: 17065461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.
    Harms JE; Benveniste M; Maclean JK; Partin KM; Jamieson C
    Neuropharmacology; 2013 Jan; 64(1):45-52. PubMed ID: 22735771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.
    Timm DE; Benveniste M; Weeks AM; Nisenbaum ES; Partin KM
    Mol Pharmacol; 2011 Aug; 80(2):267-80. PubMed ID: 21543522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.